CORC

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                        
已选(0)清除 条数/页:   排序方式:
The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study) 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Gao, Zhiliang;  Zhu, Xiang;  Lin, Bingliang;  Yi, Jianhua;  Gao, Wenjun
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/04
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文
CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 期号: 4
作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04
INCREASED SYSTEMIC HEPARANASE IN RETINAL VEIN OCCLUSION IS ASSOCIATED WITH ACTIVATION OF INFLAMMATION AND THROMBOPHILIA. 期刊论文
Retina (Philadelphia, Pa.), 2018
作者:  Hu Yijun;  Yu Yang;  Bu Zhanyun;  Cun Biyun;  Gong Yi
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04


©版权所有 ©2017 CSpace - Powered by CSpace